Literature DB >> 2900041

Lasertripsy for ureteric stones in 120 cases: lessons learned.

M J Coptcoat1, K T Ison, G Watson, J E Wickham.   

Abstract

The pulsed dye laser has proved to be an effective and safe method of treating ureteric stones; 120 patients have been treated. Ureteroscopic lasertripsy (107 cases) had an overall success rate of 84%. The failures were due to mobile stones inadvertently flushed back into the kidney (14%) and 2% of patients required open ureterolithotomy after failure of two ureteroscopic procedures. "Blind" lasertripsy (13 cases) was safe but not as efficient, the success rate being only 23%.

Entities:  

Mesh:

Year:  1988        PMID: 2900041     DOI: 10.1111/j.1464-410x.1988.tb05085.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  6 in total

1.  High-speed photographic evaluation of endoscopic lithotripsy devices.

Authors:  H J Sterenborg; T M de Reijke; J Wiersma; R C Erckens; F H Jogsma
Journal:  Urol Res       Date:  1991

Review 2.  Update on lasers in urology 2014: current assessment on holmium:yttrium-aluminum-garnet (Ho:YAG) laser lithotripter settings and laser fibers.

Authors:  Peter Kronenberg; Olivier Traxer
Journal:  World J Urol       Date:  2014-09-04       Impact factor: 4.226

Review 3.  The laser of the future: reality and expectations about the new thulium fiber laser-a systematic review.

Authors:  Peter Kronenberg; Olivier Traxer
Journal:  Transl Androl Urol       Date:  2019-09

4.  Laser lithotripsy for ureteric calculi: results in 250 patients.

Authors:  J D Kelly; P F Keane; S R Johnston; R M Kernohan
Journal:  Ulster Med J       Date:  1995-10

Review 5.  Advances in Lasers for the Treatment of Stones-a Systematic Review.

Authors:  Peter Kronenberg; Bhaskar Somani
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

6.  Tissue effects of a newly developed diode pumped pulsed Thulium:YAG laser compared to continuous wave Thulium:YAG and pulsed Holmium:YAG laser.

Authors:  Stephan Huusmann; Marcel Lafos; Ingo Meyenburg; Rolf Muschter; Heinrich-Otto Teichmann; Thomas Herrmann
Journal:  World J Urol       Date:  2021-03-16       Impact factor: 4.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.